- Home
- FRSX vs BCLI Comparison
FRSX vs BCLI Comparison
Compare FRSX & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSX
- BCLI
- Stock Information
- Founded
- FRSX N/A
- BCLI 2000
- Country
- FRSX Israel
- BCLI United States
- Employees
- FRSX N/A
- BCLI N/A
- Industry
- FRSX Computer Software: Prepackaged Software
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FRSX Technology
- BCLI Health Care
- Exchange
- FRSX Nasdaq
- BCLI Nasdaq
- Market Cap
- FRSX 9.0M
- BCLI 9.8M
- IPO Year
- FRSX 2017
- BCLI N/A
- Fundamental
- Price
- FRSX $0.50
- BCLI $1.18
- Analyst Decision
- FRSX
- BCLI Strong Buy
- Analyst Count
- FRSX 0
- BCLI 1
- Target Price
- FRSX N/A
- BCLI $30.00
- AVG Volume (30 Days)
- FRSX 480.7K
- BCLI 462.1K
- Earning Date
- FRSX 08-08-2025
- BCLI 08-13-2025
- Dividend Yield
- FRSX N/A
- BCLI N/A
- EPS Growth
- FRSX N/A
- BCLI N/A
- EPS
- FRSX N/A
- BCLI N/A
- Revenue
- FRSX $436,000.00
- BCLI N/A
- Revenue This Year
- FRSX N/A
- BCLI N/A
- Revenue Next Year
- FRSX N/A
- BCLI N/A
- P/E Ratio
- FRSX N/A
- BCLI N/A
- Revenue Growth
- FRSX N/A
- BCLI N/A
- 52 Week Low
- FRSX $0.45
- BCLI $0.72
- 52 Week High
- FRSX $2.63
- BCLI $6.45
- Technical
- Relative Strength Index (RSI)
- FRSX 45.18
- BCLI 53.24
- Support Level
- FRSX $0.45
- BCLI $1.13
- Resistance Level
- FRSX $0.54
- BCLI $1.32
- Average True Range (ATR)
- FRSX 0.05
- BCLI 0.09
- MACD
- FRSX 0.01
- BCLI 0.01
- Stochastic Oscillator
- FRSX 35.50
- BCLI 66.67
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.